Vaccine Development And Manufacturing

Vaccine Production and Manufacturing is a valuable reference on how to produce a vaccine, from beginning to end. It addresses all classes of vaccines from a processing, production, and regulatory viewpoint. It covers everything from fermentation, purification, and formulation to regulatory filing and facility design. It discusses improvements in growth media and advances in large-scale purification equipment and technology, plus new novel adjuvants. This is a key reference for medical professionals, regulatory specialists, clinical research associates, quality assurance personnel, and scientists in biotechnology, cancer therapy, immunotherapy, and medicine.

Emily Wen, PhD, is currently a Research Fellow at the Merck Research Laboratory in the department of Biological Development and Engineering. Dr. Wen has lead process developments for several major vaccine products from Phase I to Phase III clinical trials, including vaccines against hepatitis B, Haemophilus influenzae type b, Pneumococcal, Meningococcal, and Group B Streptococcus.

Ronald Ellis, PhD, is currently Chief Technology Officer at FutuRx Ltd. Dr. Ellis became responsible for Merck’s vaccine research and was cochairman of collaborations in developing pediatric combination vaccines with Pasteur-Merieux-Connaught (now Sanofi Pasteur) and CSL. He is the founding Editor-in-Chief of the journal Human Vaccines.

Hari S. Pujar, PhD, is currently a Research Fellow at the Merck Research Laboratory.

Anurag S. Rathore, PhD, is Professor in the Department of Chemical Engineering at IIT Delhi, India. He is an active member of the Parenteral Drug Association (PDA) and American Chemical Society (ACS) and has authored more than 200 publications and presentations in these areas.